在喘中预防粘膜功能障碍的AAV介导的MUC5ACsiRNA输送
Sahana Kumar1, Maria Corkran2, Yahya Cheema1
1Fischell Department of Bioengineering, University of Maryland, College Park, MD, USA.
Gene therapy
|August 23, 2025
概括
腺相关病毒6型 (AAV6) 基因治疗可以减少MUC5AC,这是喘中的关键粘液成分. 这种方法显示出恢复呼吸道清除和治疗肺部疾病中的粘液功能障碍的潜力.
科学领域:
- 肺部医学
- 基因治疗
- 呼吸系统细胞生物学
背景情况:
- 肺部的粘液主要由粘素5B (MUC5B) 和粘素5AC (MUC5AC) 组成.
- 喘的特征是增加MUC5AC的产生,损害粘膜清除 (MCC) 并导致粘液塞.
- MUC5AC是治疗喘相关气道阻塞的潜在目标.
研究的目的:
- 作为减少气道上皮细胞MUC5AC表达的基因传递载体,研究腺相关病毒6型 (AAV6).
- 在喘模型中评估AAV6介导的siRNA传递抑制MUC5AC和恢复MCC的有效性.
主要方法:
- 在体外和体内使用腺相关病毒血清型6 (AAV6) 来向呼吸道上皮细胞输送针对MUC5AC的siRNA.
- 在分泌粘液杯细胞中评估了转导效率和转基因表达.
- 用多个粒子追踪分析来评估AAV6穿透粘液屏障的能力.
- 在IL-13挑战之前,用AAV6- MUC5ACsiRNA处理人类呼吸道上皮细胞培养物,以评估MUC5AC表达和MCC.
主要成果:
- 在体外和体内,AAV6有效地转化了呼吸道上皮细胞,在杯状细胞中表达高.
- AAV6 能够透正常的和富含 MUC5AC 的粘液.
- 用AAV6- MUC5AC siRNA治疗显著降低了IL- 13刺激的HAE培养中的MUC5ACmRNA和蛋白质水平.
- 在IL-13刺激的HAE培养物中,AAV6- MUC5AC siRNA治疗维持了正常的粘膜运输.
结论:
- AAV6 作为一种有效的病毒载体,可将基因传递到气道上皮细胞,包括产生粘液的杯状细胞.
- 基于AAV6的吸入基因治疗可以抑制喘模型中的MUC5AC过度表达.
- 这种方法有望通过向MUC5AC恢复正常的呼吸道清除功能.
相关概念视频
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
452
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
452
01:20Asthma: Pathogenesis and Management
581
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
581
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
453
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
453
01:29Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
01:24Antiasthma Drugs: Methylxanthines
397
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
397
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K